New findings on the genomics impacts risk for OCD (obsessive-compulsive disorder) may help formulate new treatments for the disorder.
Impact of genomics on OCD (obsessive-compulsive disorder) may open a new door of management as per a study at The Mount Sinai Hospital / Mount Sinai School Of Medicine, published in the American Journal of Psychiatry. The study states that both rare and commonly observed differences in the DNA letters strung along a person’s chromosomes can explain about a third of the risk for being diagnosed with OCD.
‘New findings on the genomics impacts risk for OCD (obsessive-compulsive disorder) may help formulate new treatments for the disorder.’
Impact of Genomics OCD is characterized by a set of potentially life-long, debilitating, and distressing recurring thoughts and actions. It affects 2% of Americans. Previous data have found that genomic differences between individuals in a population may contribute to 25 to 50% of the risk for OCD behaviors.
The present study compared the genomic data (SNPs – single nucleotide polymorphisms, the minor DNA spelling differences) of 2,090 Swedish-born OCD individuals with 4,567 controls.
It was found that nearly 29% of the OCD risk was attributed to differences in SNPs between patients and control subjects and ~ 90% of these differences are commonly observed throughout the general population.
In addition, it was also found that about 10% of the risk could be linked to rare genomic differences – a novel finding.
Advertisement
Source-Medindia